This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

CME Academic Highlights

Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy

Thomas Roth, PhD, and John W. Winkelman, MD, PhD

Published: November 24, 2020


Sleep disorders such as narcolepsy can cause excessive daytime sleepiness (EDS). The diagnosis of narcolepsy is often delayed by years. Clinicians can improve the recognition of EDS and diagnosis of sleep disorders using screening tools such as the Epworth Sleepiness Scale and other tests. By following up with patients who present with EDS and continuing to assess until a cause is found, clinicians can lessen the time to diagnosis and initiate appropriate treatment. Fortunately, existing pharmacologic interventions are effective in reducing EDS for many patients, but elimination of EDS for most patients has not been achieved. Some interventions also show efficacy in cataplexy. Nonpharmacologic strategies should also be discussed with patients. Clinicians must monitor EDS during ongoing treatment so that residual symptoms can be addressed. Research suggests a causative role for hypocretin deficiency in narcolepsy, and treatments ameliorating this deficiency are needed.

PDF version of article
Note: To receive credit, you must navigate through the entire online activity. Click link below.

See the entire activity

J Clin Psychiatry 2020;80(6):HB19045AH3C

To cite: Roth T, Winkelman JW. Recognizing and treating excessive daytime sleepiness in patients with narcolepsy. J Clin Psychiatry. 2020;80(6):HB19045AH3C.
To share:

From the Henry Ford Hospital Sleep Center and Department of Psychiatry, Wayne State University School of Medicine, Detroit, and Department of Psychiatry, University of Michigan College of Medicine, Ann Arbor (Dr Roth); Sleep Disorders Clinical Research Program and Departments of Psychiatry and Neurology, Massachusetts General Hospital; and Department of Psychiatry, Harvard Medical School, Boston (Dr Winkelman)

© Copyright 2020 Physicians Postgraduate Press, Inc.

Volume: 81

Quick Links: Psychiatry


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...